KP Tissue (TSE:KPT – Get Free Report) had its price target decreased by analysts at TD from C$14.00 to C$13.00 in a research note issued to investors on Wednesday, BayStreet reports. The brokerage presently has a “hold” rating on the stock. TD’s price target points to a potential upside of 11.97% from the company’s current price.
KP Tissue Price Performance
Shares of KPT traded down C$0.09 during trading hours on Wednesday, hitting C$11.61. 33,058 shares of the company were exchanged, compared to its average volume of 15,450. The firm has a fifty day simple moving average of C$12.57 and a 200-day simple moving average of C$12.34. The company has a market capitalization of C$116.47 million, a PE ratio of 13.19, a PEG ratio of -0.88 and a beta of 0.54. KP Tissue has a one year low of C$9.21 and a one year high of C$13.78.
KP Tissue (TSE:KPT – Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported C$0.24 earnings per share (EPS) for the quarter. Sell-side analysts expect that KP Tissue will post 0.44 EPS for the current year.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Featured Articles
- Five stocks we like better than KP Tissue
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
